US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 9.960
- -0.070-0.70%
Trading Nov 27 11:56 ET
539.67MMarket Cap-2547P/E (TTM)
10.326High9.860Low356.49KVolume10.100Open10.030Pre Close3.59MTurnover0.67%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High1.06P/B528.64MFloat Cap1.42052wk Low--Dividend TTM53.08MShs Float137.610Historical High--Div YieldTTM4.65%Amplitude1.420Historical Low10.059Avg Price1Lot Size
About Emergent BioSolutions Company
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees1600
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200
Company Executives
- Name
- Position
- Salary
- Joseph C. Papa
- Director, President and Chief Executive Officer
- --
- Richard S. Lindahl
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 2.18M
- Coleen Glessner
- Executive Vice President, Quality and Ethics and Compliance
- 1.68M
- Paul Williams
- Senior Vice President, Products Business
- 1.06M
- Dr. Zsolt Harsanyi,PhD
- Chairman of the Board
- 535.98K
- Sujata Dayal
- Director
- 382.23K
- Ronald B. Richard
- Independent Director
- 394.73K
- Donald W. DeGolyer
- Independent Director
- 397.50K
- Neal F. Fowler
- Independent Director
- 398.75K
- Dr. Louis W. Sullivan, M.D.
- Independent Director
- 400.23K
- Keith A. Katkin
- Independent Director
- 396.99K
- Dr. Kathryn C. Zoon, PhD
- Independent Director
- 413.48K
- Marvin L. White
- Independent Director
- 405.98K
- General George A. Joulwan
- Independent Director
- 41.83K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
